2 studies found for:    3334893 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: ESHAP-Imatinib
2 Completed Humanized LL2IGG to Treat Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: hLL2 (Epratuzumab)

Indicates status has not been verified in more than two years